Oral Exposure to ZnO Nanoparticles Disrupt the Structure of Bone in Young Rats Via the OPG/RANK/RANKL/IGF-1 Pathway
Overview
Affiliations
Purpose: To evaluate the effects of ZnO NPs on bone growth in rats and explore the possible mechanisms of action.
Materials And Methods: Three-week-old male rats received ultrapure water or 68, 203, and 610 mg/kg zinc oxide nanoparticles (ZnO NPs) for 28 days, orally.
Results: The high-dosage groups caused significant differences in weight growth rate, body length, and tibia length (P<0.05), all decreasing with increased ZnO NP dosage. There were no significant differences in body mass index (BMI) (P>0.05). The zinc concentration in liver and bone tissue increased significantly with increased ZnO NP dosage (P<0.05). Clearly increased aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were observed in the 610 mg/kg ZnO NP group (P>0.05), whereas alkaline phosphatase (ALP) increased in the 610 mg/kg ZnO NP group (P<0.05). Significant differences in insulin-like growth factor type 1 (IGF-1) levels and a decrease in calcium (Ca) levels were observed in 203 and 610 mg/kg ZnO NP groups (P<0.05). Phosphorus (P) levels increased and the Ca/P ratio decreased in the 610 mg/kg ZnO NP group (P<0.05). Micro-computed tomography (micro-CT) of the tibia demonstrated signs of osteoporosis, such as decreased bone density, little trabecular bone structure and reduced cortical bone thickness. Micro-CT data further demonstrated significantly decreased bone mineral density (BMD), trabecular number (Tb.N), and relative bone volume (BV/TV) with increasing dosage of ZnO NPs. Osteoprotegerin (OPG) expression and the ratio of OPG to receptor activator of nuclear factor-κB ligand (RANKL) were statistically lower in the 610 mg/kg ZnO NP group (P<0.05), whereas RANKL expression did not change significantly (P>0.05).
Conclusion: We infer that ZnO NPs affect bone growth in young rats directly or indirectly by altering IGF-1 levels. Overall, the results indicate that ZnO NPs promote osteoclast activity and increase bone loss through the OPG/RANK/RANKL/IGF-1 pathway.
The Effects of Microplastics on Musculoskeletal Disorder; A Narrative Review.
Fusagawa H, Youn A, Wilkerson E, Pandya N, Feeley B Curr Rev Musculoskelet Med. 2024; 18(2):39-47.
PMID: 39572502 PMC: 11775366. DOI: 10.1007/s12178-024-09932-9.
Kausar S, Jabeen F, Latif M, Asad M Saudi J Biol Sci. 2023; 30(9):103745.
PMID: 37588571 PMC: 10425408. DOI: 10.1016/j.sjbs.2023.103745.
Nanoparticle Effects on Stress Response Pathways and Nanoparticle-Protein Interactions.
Cameron S, Sheng J, Hosseinian F, Willmore W Int J Mol Sci. 2022; 23(14).
PMID: 35887304 PMC: 9323783. DOI: 10.3390/ijms23147962.
Cheng W, Xu X, Lang Y, Cheng Z, Rizwan M, Tang X Int J Nanomedicine. 2021; 16:7233-7247.
PMID: 34737562 PMC: 8558833. DOI: 10.2147/IJN.S333632.